Maria Amparo
Martínez Monzonís
Publicacións (93) Publicacións de Maria Amparo Martínez Monzonís
2024
-
Diagnóstico y tratamiento de los pacientes con ANOCA Consenso SEC-Asociación de Cardiología Clínica/ SEC-Asociación de Cardiología Intervencionista/ SEC-Asociación de Cardiopatía Isquémica y Cuidados Agudos Cardiovasculares/SEC-Asociación de Imagen Cardiaca
REC: Interventional Cardiology, Vol. 6, Núm. 2, pp. 106-116
-
Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation
Journal of Cardiovascular Translational Research, Vol. 17, Núm. 1, pp. 13-23
-
Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial
Progress in Cardiovascular Diseases, Vol. 85, pp. 74-81
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
-
Fourth Report of activity and resources from the Cardiovascular Imaging Association of the Spanish Society of Cardiology (2022)
REC: CardioClinics
-
La calidad del agua en el tramo bajo del río Turia y sus implicaciones sobre el abastecimiento a Valencia
VII Jornadas de Ingeniería del Agua: La resiliencia de las infraestructuras hidráulicas frente al cambio climático. Libro de actas (Universidad Politécnica de Cartagena), pp. 501-504
-
Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63
Scientific Reports, Vol. 14, Núm. 1
-
Phenotypic Expression and Outcomes in Patients with the p.Arg301Gln GLA Variant in Anderson-Fabry Disease
International journal of molecular sciences, Vol. 25, Núm. 8
-
Prevalence of Fabry disease in patients with left ventricular hypertrophy and renal involvement (PrEFaCe)
Medicina Clinica, Vol. 163, Núm. 10, pp. 503-508
-
Tratamiento de borde a borde en la insuficiencia mitral aguda. Propuesta de protocolo asistencial de las Asociaciones de Cardiopatía Isquémica y Cuidados Agudos Cardiovasculares, de Cardiología Intervencionista y de Imagen Cardiaca de la Sociedad Española de Cardiología
REC: Interventional Cardiology, Vol. 6, Núm. 4, pp. 313-320
-
Videolaryngoscope versus conventional technique for insertion of a transesophageal echocardiography probe in intubated ICU patients (VIDLARECO trial): A randomized clinical trial
Anaesthesia Critical Care and Pain Medicine, Vol. 43, Núm. 2
2023
-
A clinician-to-clinician universal electronic consultation programme at the cardiology department of a Galician healthcare area improves healthcare accessibility and outcomes in elderly patients
European Heart Journal - Digital Health, Vol. 4, Núm. 2, pp. 90-98
-
Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation
Cells, Vol. 12, Núm. 4
-
Effects of guideline-directed medical therapy in patients with left bundle branch block-induced cardiomyopathy
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 238-244
-
Plasma miR-486-5p Expression Is Upregulated in Atrial Fibrillation Patients with Broader Low-Voltage Areas
International Journal of Molecular Sciences, Vol. 24, Núm. 20
-
Radiation protection in interventional echocardiography. Recommendations of the SEC-Cardiovascular Imaging Association/SEC-Interventional Cardiology Association
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 956-960
-
Results of a focused cardiac ultrasound program conducted by neurologists within a stroke care network with cardiac imaging units
Revista Espanola de Cardiologia, Vol. 76, Núm. 2, pp. 103-111
-
Selection of the best of 2022 in cardiac imaging
REC: CardioClinics, Vol. 58, pp. S28-S34
2022
-
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry
European journal of preventive cardiology, Vol. 29, Núm. 6, pp. 859-868
-
Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy
Cells, Vol. 11, Núm. 2